Halozyme Therapeutics Inc... (HALO)
NASDAQ: HALO
· Real-Time Price · USD
60.11
-1.31 (-2.13%)
At close: May 01, 2025, 3:59 PM
60.01
-0.17%
After-hours: May 01, 2025, 05:47 PM EDT
13F Institute Ownership
Total Institutes of 518 in Halozyme Therapeutics expanded their positions with an increase of 0 investors compared to the previous quarter. A reduction of 1.74M shares, as total invested capital declined by $1.25B with ownership percentage dropping from 98.85% to 97.48%.
Options Activity
Institutions are holding more Calls Contracts as Puts Contracts, indicating a bullish sentiment.
Put/Call 0.388
0.39
Call Flow 667,903
72%
Put Flow 259,300
28%
Top Shareholders
| Institute | Ownership | Shares | Shares % Change | Market Value | Portfolio |
|---|---|---|---|---|---|
| Blackrock, Inc. | 13.85% | 17.57M | +0.78% | 839.84M | 0.02% |
| Vanguard Group Inc | 10.47% | 13.28M | +3.00% | 635M | 0.01% |
| State Street Corp | 5.66% | 7.18M | +8.31% | 343.5M | 0.01% |
Stop Guessing, Start Knowing.
Cut through market noise with actionable insights that actually help you make confident investment decisions. No more endless research or gut-based guessing.
- Unlimited access to all data and tools
- Unlimited access to all data and tools, giving you the edge over everyone else in the market.
- Realtime Options & Dark Pool Data
- Instant access to live options & dark pool data to spot opportunities and trade with precision before the market moves.
- Top Wallstreet Analyst Ratings
- Follow ratings from the best analysts on Wall Street to stay ahead.
- Up to 30 years financial history
- We deliver premium Wall Street data with top-tier accuracy and up to 30 years of history.